Observe the therapeutic effect of 3% dexamethasone eye drops on chemical eye injury based on goblet cell and ocular surface mucin levels

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064663

Enrollment

Unknown

Registered

2022-10-13

Start date

2022-10-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ocular chemical burns

Interventions

Treatment group:Dexamethoxol sodium 0.3% eye drops were added to routine treatment

Control group:Routine treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Grade I-II ocular chemical injury, aged 40-60 years.

Exclusion criteria

Exclusion criteria: 1. There were obvious corneal infection, corneal lysis, ocular hypertension, dacryocystitis, intraocular inflammation, diabetes mellitus, systemic immune diseases and so on.

Design outcomes

Primary

Measure	Time frame
Conjunctival goblet cells;Conjunctival goblet cells;Complication;	—

Countries

China

Contacts

Public ContactNiu Xiaoguang

Aier eye hospital of Wuhan university

13476186008@163.com+86 13476186008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026